Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Mycobacterium tuberculosis cell envelope is a highly complex and unique multi-layered structure that serves as the primary interface between the bacterium and its host. It is characterized by a core mAGP complex consisting of peptidoglycan covalently linked to arabinogalactan, which is in turn esterified to long-chain mycolic acids (Dulberger et al., 2020, Nature Reviews Microbiology). This lipid-rich mycomembrane creates an exceptionally impermeable barrier that protects the pathogen from host immune effector mechanisms and many standard antibiotics (Brennan, 2003, Tuberculosis). Because several components of the envelope are unique to mycobacteria, they represent ideal targets for therapeutic intervention. Frontline drugs like isoniazid and ethambutol work by disrupting the synthesis of mycolic acids and arabinogalactan, respectively, leading to cell wall instability and bacterial death (Goude & Parish, 2008, Future Microbiology). The envelope also contains various glycolipids and proteins that modulate the host immune response, contributing significantly to the pathogenesis of tuberculosis (Jackson, 2014, Cold Spring Harbor Perspectives in Medicine). Furthermore, the envelope's dynamic nature allows the bacterium to adapt to different environments within the host, such as the acidic conditions of the phagosome (Marrakchi et al., 2014, Microbiology Spectrum).
Inhibition of mycolic acid biosynthesis, inhibition of arabinogalactan synthesis, inhibition of peptidoglycan cross-linking, and disruption of the mycobacterial outer membrane integrity.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterium tuberculosis cell envelope (Mtb cell envelope).